Molecular Imaging LitBriefs - May 2012
A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle.
http://www.ncbi.nlm.nih.gov/pubmed/22504484
Kircher MF, de la Zerda A, Jokerst JV, Zavaleta CL, Kempen PJ, Mittra E, Pitter K, Huang R, Campos C, Habte F, Sinclair R, Brennan CW, Mellinghoff IK, Holland EC, Gambhir SS.
Nat Med. 2012 Apr 15. doi: 10.1038/nm.2721.
CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma.
http://www.ncbi.nlm.nih.gov/pubmed/22494888
Wang L, Su W, Liu Z, Zhou M, Chen S, Chen Y, Lu D, Liu Y, Fan Y, Zheng Y, Han Z, Kong D, Wu JC, Xiang R, Li Z.
Biomaterials. 2012 Apr 9.
Comparison of (64)Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability.
http://www.ncbi.nlm.nih.gov/pubmed/22471317
Cooper MS, Ma MT, Sunassee K, Shaw KP, Williams JD, Paul RL, Donnelly PS, Blower PJ.
Bioconjug Chem. 2012 Apr 13. [Epub ahead of print]
Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
http://www.ncbi.nlm.nih.gov/pubmed/22475532
Lee JH, Jung MJ, Hwang YH, Lee YJ, Lee S, Lee DY, Shin H.
Biomaterials. 2012 Apr 2.
Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 tesla.
http://www.ncbi.nlm.nih.gov/pubmed/22469244
Loai Y, Sakib N, Janik R, Foltz WD, Margaret Cheng HL.
Mol Imaging. 2012 Apr 1;11(2):166-75.
Molecular imaging of cell death in an experimental model of Parkinson's disease with a novel apoptosis-targeting peptide.
http://www.ncbi.nlm.nih.gov/pubmed/21567253
Lee MJ, Wang K, Kim IS, Lee BH, Han HS.
Mol Imaging Biol. 2012 Apr;14(2):147-55.
Molecular Imaging of Human ACE-1 Expression in Transgenic Rats.
http://www.ncbi.nlm.nih.gov/pubmed/22498331
Dilsizian V, Zynda TK, Petrov A, Ohshima S, Tahara N, Haider N, Donohue A, Aras O, Femia FJ, Hillier SM, Joyal JL, Wong ND, Coleman T, Babich JW, Narula J.
JACC Cardiovasc Imaging. 2012 Apr;5(4):409-18.
Molecular Imaging of Very Late Antigen-4 (α4β1 Integrin) in the Premetastatic Niche.
http://www.ncbi.nlm.nih.gov/pubmed/22496586
Shokeen M, Zheleznyak A, Wilson JM, Jiang M, Liu R, Ferdani R, Lam KS, Schwarz JK, Anderson CJ.
J Nucl Med. 2012 Apr 10. [Epub ahead of print]
N-(4-18F-Fluorobenzoyl)Interleukin-2 for PET of Human-Activated T Lymphocytes.
http://www.ncbi.nlm.nih.gov/pubmed/22499614
Gialleonardo VD, Signore A, Glaudemans A, Dierckx R, De Vries E.
J Nucl Med. 2012 Apr 12. [Epub ahead of print]
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions.
http://www.ncbi.nlm.nih.gov/pubmed/22461363
Broisat A, Hernot S, Toczek J, De Vos J, Riou LM, Martin S, Ahmadi M, Thielens N, Wernery U, Caveliers V, Muyldermans S, Lahoutte T, Fagret D, Ghezzi C, Devoogdt N.
Circ Res. 2012 Mar 30;110(7):927-37.
Single-Photon Emission Computed Tomographic Imaging of the Early Time Course of Therapy-Induced Cell Death Using Technetium 99m Tricarbonyl His-annexin A5 in a Colorectal Cancer Xenograft Model.
http://www.ncbi.nlm.nih.gov/pubmed/22469241
Vangestel C, Van de Wiele C, Mees G, Mertens K, Staelens S, Reutelingsperger C, Pauwels P, Van Damme N, Peeters M.
Mol Imaging. 2012 Apr 1;11(2):135-47.
Ultrasonic microbubbles: vehicles for molecular imaging and localized drug delivery.
http://www.ncbi.nlm.nih.gov/pubmed/22501326
Zheng H.
J Acoust Soc Am. 2012 Apr;131(4):3245.